newsfilter
← Latest News
PR Newswire·

NLS Pharmaceutics and Kadimastem Announce Pricing and Closing of $1 Million Equity Financing

NLS Pharmaceutics Ltd. (NASDAQ: NLSP) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on developing therapies for...